Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

KalVista Pharmaceuticals (KALV) Return on Sales (2016 - 2021)

KalVista Pharmaceuticals' Return on Sales history spans 8 years, with the latest figure at 12.52% for Q1 2021.

  • For Q1 2021, Return on Sales fell 469.0% year-over-year to 12.52%; the TTM value through Jan 2021 reached 12.52%, down 905.0%, while the annual FY2025 figure was 16.43%, 1896.0% up from the prior year.
  • Return on Sales for Q1 2021 was 12.52% at KalVista Pharmaceuticals, down from 8.83% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.6% in Q2 2018 and bottomed at 56.78% in Q3 2017.
  • The 5-year median for Return on Sales is 3.72% (2019), against an average of 11.22%.
  • The largest annual shift saw Return on Sales crashed -5154bps in 2017 before it skyrocketed 5492bps in 2018.
  • A 5-year view of Return on Sales shows it stood at 5.27% in 2017, then surged by 84bps to 0.84% in 2018, then plummeted by -167bps to 2.24% in 2019, then crashed by -294bps to 8.83% in 2020, then plummeted by -42bps to 12.52% in 2021.
  • Per Business Quant, the three most recent readings for KALV's Return on Sales are 12.52% (Q1 2021), 8.83% (Q4 2020), and 4.71% (Q3 2020).